Unlearn.AI provides a groundbreaking product that leverages artificial intelligence to transform clinical trials. Utilizing digital twin technology, Unlearn.AI enables medical researchers to conduct quicker and more accurate clinical trials. By virtually simulating patients, this technology reduces the need for large control groups, enhances trial efficiency, and accelerates the development of personalized medical treatments. This approach not only saves time and resources but also improves the accuracy and reliability of clinical trials.

Isomorphic Labs focuses on harnessing the power of artificial intelligence to improve drug discovery. By using AI-driven models, it assists researchers in predicting molecular interactions and optimizing compounds, facilitating the design of new medications with enhanced precision and speed. The platform aims to reduce the time and cost associated with traditional drug development methods.